[video+transcript]Could Late-Stage Coronavirus Vaccine Trials Fail?

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 23, 2020 at 10:12 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,973
    Likes Received:
    3
    via Pfizer (NYSE:pFE) and its German partner BioNTech (NASDAQ:BNTX) reported incredible efficacy data from a phase 3 trial for their mRNA coronavirus vaccine candidate. This news, paired with the equally impressive data from Moderna (NASDAQ:MRNA) about its candidate that takes a similar approach, inspired much hope around the world and injected optimism into the stock market.

    article source